Exploring Time-Resolved Characterization of the Heterogeneity and Dynamics of Ligand-Receptor Interactions on Living Cells

作者: Pavel Barta , , Karl Andersson , Frantisek Trejtnar , Jos Buijs

DOI: 10.6000/1927-7229.2014.03.02.4

关键词:

摘要: Patients affected by malignant brain tumor present an extremely poor prognosis, notwithstanding improvements in surgery techniques and therapeutic protocols. Late diagnosis the limitation of conventional therapies are major reasons for this unsolved clinical problem. The blood-brain barrier formed a complex endothelial cells, astrocyte pericytes reduces notably diffusion large number agents. Nanotechnology involves design, synthesis, characterization materials devices that have functional organization at least one dimension on nanometer scale. nanoparticles emerged as potential vectors delivery able to overcome difficulties modern strategies. Nanoparticles drug systems can be, also, used provide targeted drugs, improve bioavailability, sustains release drugs systemic delivery. Moreover, multi-functionality be engineered into single nanoplatform so it tumor-specific detection, treatment, follow-up monitoring. In study we will focus role possibilities its overcoming. Recent studies some kinds tumors treatment summarized.

参考文章(48)
Johan Nilvebrant, Gamze Kuku, Hanna Björkelund, Marika Nestor, None, Selection andin vitrocharacterization of human CD44v6-binding antibody fragments Biotechnology and Applied Biochemistry. ,vol. 59, pp. 367- 380 ,(2012) , 10.1002/BAB.1033
D.R. Hurwitz, S.L. Emanuel, M.H. Nathan, N. Sarver, A. Ullrich, S. Felder, I. Lax, J. Schlessinger, EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain. Journal of Biological Chemistry. ,vol. 266, pp. 22035- 22043 ,(1991) , 10.1016/S0021-9258(18)54741-4
HANNA BJÖRKELUND, LARS GEDDA, MAGNUS MALMQVIST, KARL ANDERSSON, Resolving the EGF-EGFR interaction characteristics through a multiple-temperature, multiple-inhibitor, real-time interaction analysis approach Molecular and Clinical Oncology. ,vol. 1, pp. 343- 352 ,(2013) , 10.3892/MCO.2012.37
Mark M. Moasser, Steven D. Averbuch, Neal Rosen, Andrea Basso, The Tyrosine Kinase Inhibitor ZD1839 ("Iressa") Inhibits HER2-driven Signaling and Suppresses the Growth of HER2-overexpressing Tumor Cells Cancer Research. ,vol. 61, pp. 7184- 7188 ,(2001)
FC GREENWOOD, WM HUNTER, JS GLOVER, THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY Biochemical Journal. ,vol. 89, pp. 114- 123 ,(1963) , 10.1042/BJ0890114
Zbynek Novy, Pavel Barta, Jana Mandikova, Milan Laznicek, Frantisek Trejtnar, A comparison of in vitro methods for determining the membrane receptor expression in cell lines Nuclear Medicine and Biology. ,vol. 39, pp. 893- 896 ,(2012) , 10.1016/J.NUCMEDBIO.2012.02.007
Göran Dahl, Tomas Akerud, Pharmacokinetics and the drug–target residence time concept Drug Discovery Today. ,vol. 18, pp. 697- 707 ,(2013) , 10.1016/J.DRUDIS.2013.02.010
Annica Önell, Karl Andersson, Kinetic determinations of molecular interactions using Biacore—minimum data requirements for efficient experimental design Journal of Molecular Recognition. ,vol. 18, pp. 307- 317 ,(2005) , 10.1002/JMR.745